OBJECTIVE: An imbalance of excitatory and inhibitory neurotransmission in autism spectrum disorder (ASD) has been proposed. We compared glutamate (Glu), glutamine (Gln), and γ-aminobutyric acid (GABA) levels in the anterior cingulate cortex (ACC) of 13 males with ASD and 14 typically developing (TD) males (ages 13-17), and correlated these levels with intelligence quotient (IQ) and measures of social cognition. METHODS: Social cognition was evaluated by administration of the Social Responsiveness Scale (SRS) and the Reading the Mind in the Eyes Test (RMET). We acquired proton magnetic resonance spectroscopy ((1)H-MRS) data from the bilateral ACC using the single voxel point resolved spectroscopy sequence (PRESS) to quantify Glu and Gln, and Mescher-Garwood point-resolved spectroscopy sequence (MEGA-PRESS) to quantify GABA levels referenced to creatine (Cr). RESULTS: There were higher Gln levels (p=0.04), and lower GABA/Cre levels (p=0.09) in the ASD group than in the TD group. There was no difference in Glu levels between groups. Gln was negatively correlated with RMET score (rho=-0.62, p=0.001) and IQ (rho=-0.56, p=0.003), and positively correlated with SRS scores (rho=0.53, p=0.007). GABA/Cre levels were positively correlated with RMET score (rho=0.34, p=0.09) and IQ (rho=0.36, p=0.07), and negatively correlated with SRS score (rho=-0.34, p=0.09). CONCLUSIONS: These data suggest an imbalance between glutamatergic neurotransmission and GABA-ergic neurotransmission in ASD. Higher Gln levels and lower GABA/Cre levels were associated with lower IQ and greater impairments in social cognition across groups.
OBJECTIVE: An imbalance of excitatory and inhibitory neurotransmission in autism spectrum disorder (ASD) has been proposed. We compared glutamate (Glu), glutamine (Gln), and γ-aminobutyric acid (GABA) levels in the anterior cingulate cortex (ACC) of 13 males with ASD and 14 typically developing (TD) males (ages 13-17), and correlated these levels with intelligence quotient (IQ) and measures of social cognition. METHODS:Social cognition was evaluated by administration of the Social Responsiveness Scale (SRS) and the Reading the Mind in the Eyes Test (RMET). We acquired proton magnetic resonance spectroscopy ((1)H-MRS) data from the bilateral ACC using the single voxel point resolved spectroscopy sequence (PRESS) to quantify Glu and Gln, and Mescher-Garwood point-resolved spectroscopy sequence (MEGA-PRESS) to quantify GABA levels referenced to creatine (Cr). RESULTS: There were higher Gln levels (p=0.04), and lower GABA/Cre levels (p=0.09) in the ASD group than in the TD group. There was no difference in Glu levels between groups. Gln was negatively correlated with RMET score (rho=-0.62, p=0.001) and IQ (rho=-0.56, p=0.003), and positively correlated with SRS scores (rho=0.53, p=0.007). GABA/Cre levels were positively correlated with RMET score (rho=0.34, p=0.09) and IQ (rho=0.36, p=0.07), and negatively correlated with SRS score (rho=-0.34, p=0.09). CONCLUSIONS: These data suggest an imbalance between glutamatergic neurotransmission and GABA-ergic neurotransmission in ASD. Higher Gln levels and lower GABA/Cre levels were associated with lower IQ and greater impairments in social cognition across groups.
Authors: Charles Gasparovic; Tao Song; Deidre Devier; H Jeremy Bockholt; Arvind Caprihan; Paul G Mullins; Stefan Posse; Rex E Jung; Leslie A Morrison Journal: Magn Reson Med Date: 2006-06 Impact factor: 4.668
Authors: Peter G Enticott; Bernadette M Fitzgibbon; Hayley A Kennedy; Sara L Arnold; David Elliot; Amy Peachey; Abraham Zangen; Paul B Fitzgerald Journal: Brain Stimul Date: 2013-10-27 Impact factor: 8.955
Authors: Adam J Guastella; Stewart L Einfeld; Kylie M Gray; Nicole J Rinehart; Bruce J Tonge; Timothy J Lambert; Ian B Hickie Journal: Biol Psychiatry Date: 2009-11-07 Impact factor: 13.382
Authors: Lisa A Page; Eileen Daly; Nicole Schmitz; Andrew Simmons; Fiona Toal; Quinton Deeley; Fiona Ambery; Grainne M McAlonan; Kieran C Murphy; Declan G M Murphy Journal: Am J Psychiatry Date: 2006-12 Impact factor: 18.112
Authors: Manuel F Casanova; Mohamed Shaban; Mohammed Ghazal; Ayman S El-Baz; Emily L Casanova; Estate M Sokhadze Journal: Appl Psychophysiol Biofeedback Date: 2021-04-20
Authors: Jennifer H Foss-Feig; Brendan D Adkinson; Jie Lisa Ji; Genevieve Yang; Vinod H Srihari; James C McPartland; John H Krystal; John D Murray; Alan Anticevic Journal: Biol Psychiatry Date: 2017-03-14 Impact factor: 13.382
Authors: Murat İlhan Atagün; Elif Muazzez Şıkoğlu; Çağlar Soykan; Can Serdar Süleyman; Semra Ulusoy-Kaymak; Ali Çayköylü; Oktay Algın; Mary Louise Phillips; Dost Öngür; Constance Mary Moore Journal: Neurosci Lett Date: 2016-11-24 Impact factor: 3.046
Authors: Manuel F Casanova; Estate M Sokhadze; Emily L Casanova; Ioan Opris; Caio Abujadi; Marco Antonio Marcolin; Xiaoli Li Journal: Psychiatr Clin North Am Date: 2020-04-08
Authors: Tamar Kolodny; Michael-Paul Schallmo; Jennifer Gerdts; Richard A E Edden; Raphael A Bernier; Scott O Murray Journal: Autism Res Date: 2020-04-16 Impact factor: 5.216
Authors: Gerhard S Drenthen; Evelien M Barendse; Albert P Aldenkamp; Tamar M van Veenendaal; Nicolaas A J Puts; Richard A E Edden; Svitlana Zinger; Geert Thoonen; Marc P H Hendriks; Roy P C Kessels; Jacobus F A Jansen Journal: Psychiatry Res Neuroimaging Date: 2016-09-20 Impact factor: 2.376
Authors: Remmelt R Schür; Luc W R Draisma; Jannie P Wijnen; Marco P Boks; Martijn G J C Koevoets; Marian Joëls; Dennis W Klomp; René S Kahn; Christiaan H Vinkers Journal: Hum Brain Mapp Date: 2016-05-04 Impact factor: 5.038